Fundraising Fox

Nobiastx

1 known investors

Find your way into Nobiastx

163 people in our graph share verified history with the Nobiastx team — schools, employers, funds. One of them is your warm intro.

Wesley Barrowunlockedknows Brian Halak · together at University of Pennsylvania (overlapped)
×3knows the team · via University of Pennsylvania
×7knows the team · via Medical Excellence Capital
knows the team · via Domain Associates

Nobias Therapeutics is a clinical-stage drug developer creating small-molecule therapeutics for genetically-defined rare diseases, initially focused on pediatric indications with potential expansion into adult and non-rare conditions. It uses genomic and health datasets alongside relationships with pediatric academic medical centers across North America to advance drug discovery.

Founders & leadership

HHHakon Hakonarson
Hakon HakonarsonCo-Founder and Chief Scientific Advisor
BHBrian Halak
Brian HalakinCo-FounderManaging Partner at Medical Excellence Capital
PDPatrick Dougherty
Patrick DoughertyChief Executive Officer
RMRyan McMillian
Ryan McMillianConsulting Chief Financial Officer

Investors · 1

Competitors · 2

by search overlap

Companies competing with Nobiastx for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Nobiastx do?
Nobias Therapeutics is a clinical-stage drug developer creating small-molecule therapeutics for genetically-defined rare diseases, initially focused on pediatric indications with potential expansion into adult and non-rare conditions. It uses genomic and health datasets alongside relationships with pediatric academic medical centers across North America to advance drug discovery.
Who founded Nobiastx?
Nobiastx was founded by Hakon Hakonarson, Brian Halak.
Who are Nobiastx's investors?
Nobiastx's investors include Medical Excellence Capital.